Non-epithelial ovarian tumors are heterogeneous and account for approximately 10% of
ovarian malignancies. The most common subtypes of non-epithelial ovarian tumors arise …

The need for new drugs is compelling, irrespective of the disease. Focusing on medical
problems in the Western countries, heart disease and cancer are at the moment …

Abstract Maxim Sorokin 1, 2, 3, Roman Kholodenko 3, Anna Grekhova 4, Maria Suntsova 1,
5, Margarita Pustovalova 4, Natalia Vorobyeva 1, 4, Irina Kholodenko 6, Galina Malakhova …

Background: Lactate dehydrogenase (LDH) is a marker of injury and disease as it is
expressed extensively in numerous cell types and tissues. Moreover it is released during …

Purpose Pancreatic ductal adenocarcinoma (PDAC) has a five-year survival rate of less than
5%. Absence of symptoms at primary tumor stages, as well as high aggressiveness of the …

Aim The description of rare malignant ovarian tumours and the most suitable treatments.
Alternative therapies different from intravenous chemotherapy are also explained. Methods …

Aim To evaluate the efficacy and toxicity of external beam radiotherapy (RT) for isolated
recurrent epithelial ovarian cancer (EOC). Methods Twenty‐four isolated recurrent EOC …

The mortality rate of epithelial ovarian carcinoma (EOC) ranks the highest in all
gynecological malignancies, although it is the third common cancer in the female …

目的通过蛋白质磷酸化修饰组学质谱测序, 分析蛋白激酶WNK2 在卵巢癌细胞中调控的生物过程
. 方法用WNK2 干扰慢病毒感染SKOV3 细胞系, 药筛获得稳转细胞株, 提取总蛋白进行蛋白质 …

This study aims to determine ovarian cancer (OC) patients with platinum resistance for
alternative treatment protocols by using metabolomic methodologies. Urine and serum …